This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. tumbled 10.2% to $10.15 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.4% to 19,523.40 and Dow Jones Industrial Average falling 1.0% to 44,303.40.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 83.6% below its 52-week high of $61.90, which the company achieved on July 31st.
The stock underperformed when compared to some of its competitors, as Vanda Pharmaceuticals Inc. rose 2.3% to $4.80, Fortress Biotech Inc. fell 2.5% to $1.79, and Viking Therapeutics Inc. rose 3.50% to $32.56.
Trading volume totaled 283,864, compared to the 50-day average of 255,910.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 07, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。